Assignee
HERON THERAPEUTICS INC
US·34 granted patents·23 pending applications·230 citations·filing 2013–2025
Top patents by PatentIndex Score
57 records- 0199US11173118B2Emulsion formulations of an NK-1 receptor antagonist and uses thereofHERON THERAPEUTICS INC·Filed 2020·Granted Nov 16, 2021·13 cites·18 claims
- 0298US11878074B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2021·Granted Jan 23, 2024·7 cites·14 claims
- 0398US11744800B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2022·Granted Sep 5, 2023·7 cites·30 claims
- 0498US10953018B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2019·Granted Mar 23, 2021·12 cites·18 claims
- 0598US10624850B2Emulsion formulations of an NK-1 receptor antagonist and uses thereofHERON THERAPEUTICS INC·Filed 2018·Granted Apr 21, 2020·12 cites·16 claims
- 0698US9974742B2Emulsion formulations of an NK-1 receptor antagonist and uses thereofHERON THERAPEUTICS INC·Filed 2016·Granted May 22, 2018·18 cites·23 claims
- 0797US9974793B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·18 cites·22 claims
- 0897US9808465B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2015·Granted Nov 7, 2017·23 cites·15 claims
- 0997US9561229B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2016·Granted Feb 7, 2017·22 cites·21 claims
- 1096US10500208B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2017·Granted Dec 10, 2019·15 cites·17 claims
- 1196US9974794B2Emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·14 cites·21 claims
- 1296US9801945B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2016·Granted Oct 31, 2017·9 cites·30 claims
- 1396US9694079B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2016·Granted Jul 4, 2017·19 cites·14 claims
- 1495US11413350B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2020·Granted Aug 16, 2022·3 cites·110 claims
- 1592US10632199B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2018·Granted Apr 28, 2020·3 cites·20 claims
- 1692US10213510B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2015·Granted Feb 26, 2019·10 cites·19 claims
- 1791US12290520B2Methods of use of emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2024·Granted May 6, 2025·0 cites·24 claims
- 1891US10098957B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·3 cites·24 claims
- 1987US12115255B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2024·Granted Oct 15, 2024·0 cites·30 claims
- 2087US11253504B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2019·Granted Feb 22, 2022·1 cites·15 claims
- 2186US12115254B2Methods of use of emulsion formulations of an NK-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2024·Granted Oct 15, 2024·0 cites·30 claims
- 2285US11083730B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2016·Granted Aug 10, 2021·2 cites·54 claims
- 2385US11083797B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2017·Granted Aug 10, 2021·1 cites·20 claims
- 2485US10898575B2Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2017·Granted Jan 26, 2021·3 cites·79 claims
- 2584US2025228867A1Methods of use of emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2684US2024238197A1Methods of use of emulsion formulations of an nk-1 receptor antagonistHERON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2784US2025161458A1Compositions of a polyorthoester and an organic acid excipientHERON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2883US10398686B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2017·Granted Sep 3, 2019·2 cites·10 claims
- 2982US9446036B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2014·Granted Sep 20, 2016·5 cites·14 claims
- 3081US12318376B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2022·Granted Jun 3, 2025·0 cites·19 claims
- 3181US10357570B2Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetronHERON THERAPEUTICS INC·Filed 2018·Granted Jul 23, 2019·1 cites·17 claims
- 3280US9913909B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2016·Granted Mar 13, 2018·2 cites·15 claims
- 3380US9592227B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2014·Granted Mar 14, 2017·3 cites·25 claims
- 3478US2021252156A1Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetronHERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3577US10980886B2Compositions of a polyorthoester and an organic acid excipientHERON THERAPEUTICS INC·Filed 2015·Granted Apr 20, 2021·1 cites·7 claims
- 3677US2021186981A1Methods of use of emulsion formulations of aprepitantHERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3776US2020405866A1Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetronHERON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3875US2021330796A1Long-acting polymeric delivery systemsHERON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3974US11844837B2Compositions of a polyorthoester and an organic acid excipientHERON THERAPEUTICS INC·Filed 2021·Granted Dec 19, 2023·0 cites·9 claims
- 4071US9744163B2Compositions of a polyorthoester and an aprotic solventHERON THERAPEUTICS INC·Filed 2014·Granted Aug 29, 2017·1 cites·21 claims
- 4171US2025387487A1Compositions of a polyorthoester and an organic acid excipientHERON THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4267US2021338820A1Pharmaceutical composition comprising antiemetic compounds and polyorthoesterHERON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4367US2014371187A1Semi-solid delivery vehicle and pharmaceutical compositionsHERON THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4466US9913910B2Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetronHERON THERAPEUTICS INC·Filed 2016·Granted Mar 13, 2018·0 cites·18 claims
- 4566US2015320866A1Pharmaceutical composition comprising antiemetic compounds and polyorthoesterHERON THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4664US2024307266A1Vial access needle deviceHERON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4763US2020061035A1Long-acting polymeric delivery systems comprising olanzapine and a 5-ht3 receptor antagonistHERON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4862US2017232107A1Pharmaceutical composition comprising antiemetic compounds and polyorthoesterHERON THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4960US2014323517A1Compositions and methods for injection of a biodegradable polymer-based delivery systemHERON THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 5056US2017340740A1Long-acting polymeric delivery systems comprising olanzapine and a 5-ht3 receptor antagonistHERON THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when HERON THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →